{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:35:18Z","timestamp":1773779718993,"version":"3.50.1"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic research Project of Henan Provincial Key Scientific Research Project","award":["19zx009"],"award-info":[{"award-number":["19zx009"]}]},{"name":"Science and Technology Project for Tackling Key Problems of Henan Province","award":["212102310639"],"award-info":[{"award-number":["212102310639"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastric cancer (GC) is one of the most common types of tumors and the most common cause of cancer mortality worldwide. The diagnosis of GC is critical to its prevention and treatment. Available tumor markers are the crucial step for GC diagnosis. Recent studies have shown that proteins in exosomes are potential diagnostic and prognostic markers for GC. Exosomes, secreted by cells, are cup-shaped with a diameter of 30\u2013150\u00a0nm under the electron microscope. They are also surrounded by lipid bilayers and are widely found in various body fluids. Exosomes contain proteins, lipids and nucleic acid. The examination of exosomal proteins has the advantages of quickness, easy sampling, and low pain and cost, as compared with the routine inspection method of GC, which may lead to marked developments in GC diagnosis. This article summarized the exosomal proteins with a diagnostic and prognostic potential in GC, as well as exosomal proteins involved in GC progression.<\/jats:p>","DOI":"10.1007\/s10238-022-00793-5","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T18:02:31Z","timestamp":1642874551000},"page":"203-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article)"],"prefix":"10.1007","volume":"23","author":[{"given":"Hang","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-4319","authenticated-orcid":false,"given":"Weihong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13046-018-0825-0","volume":"37","author":"H Fu","year":"2018","unstructured":"Fu H, Yang H, Zhang X, et al. Exosomal TRIM3 is a novel marker and therapy target for gastric cancer. J Exp Clin Cancer Res CR. 2018;37:162.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1757-2215-7-14","volume":"7","author":"A Beach","year":"2014","unstructured":"Beach A, Zhang HG, Ratajczak MZ, Kakar SS. Exosomes: an overview of biogenesis, composition and role in ovarian cancer. J Ovarian Res. 2014;7:14.","journal-title":"J Ovarian Res"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12026-014-8490-7","volume":"58","author":"S Levy","year":"2014","unstructured":"Levy S. Function of the Tetraspanin molecule CD81 in B and T cells. Immunol Res. 2014;58:179\u201385.","journal-title":"Immunol Res"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1021\/acs.molpharmaceut.9b00409","volume":"16","author":"L Jiang","year":"2019","unstructured":"Jiang L, Gu Y, Du Y, Liu J. Exosomes: diagnostic biomarkers and therapeutic delivery vehicles for cancer. Mol Pharm. 2019;16:3333\u201349.","journal-title":"Mol Pharm"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"693360","DOI":"10.3389\/fonc.2021.693360","volume":"11","author":"X Qian","year":"2021","unstructured":"Qian X, Xie F, Wei H, Cui D. Identification of key circulating exosomal microRNAs in gastric cancer. Front Oncol. 2021;11:693360.","journal-title":"Front Oncol"},{"issue":"18","key":"793_CR7","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2217\/bmm-2021-0327","volume":"15","author":"Z Han","year":"2021","unstructured":"Han Z, Li K, Wu J, et al. Diagnostic value of RNA for hepatocellular carcinoma: a network meta-analysis. Biomark Med. 2021;15(18):1755-1767.","journal-title":"Biomark Med."},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12957-021-02395-z","volume":"19","author":"W Han","year":"2021","unstructured":"Han W, Bu X, Liu Y, et al. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer. World J Surg Oncol. 2021;19:283.","journal-title":"World J Surg Oncol"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12876-017-0641-6","volume":"17","author":"Y Tong","year":"2017","unstructured":"Tong Y, Wu Y, Song Z, Yu Y, Yu X. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. BMC Gastroenterol. 2017;17:88.","journal-title":"BMC Gastroenterol"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/ajg.2017.55","volume":"112","author":"H Tu","year":"2017","unstructured":"Tu H, Sun L, Dong X, et al. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. Am J Gastroenterol. 2017;112:704\u201315.","journal-title":"Am J Gastroenterol"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4149\/neo_2018_180825N647","volume":"66","author":"G Yu","year":"2019","unstructured":"Yu G, Wang GX, Wang HG, Mo FF, Tang BB. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer. Neoplasma. 2019;66:637\u201340.","journal-title":"Neoplasma"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.biopha.2017.09.032","volume":"95","author":"M Abbas","year":"2017","unstructured":"Abbas M, Habib M, Naveed M, et al. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice. Biomed Pharmacother Biomed Pharmacother. 2017;95:1082\u201390.","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.33160\/yam.2019.06.002","volume":"62","author":"M Osaki","year":"2019","unstructured":"Osaki M, Okada F. Exosomes and their role in cancer progression. Yonago Acta Med. 2019;62:182\u201390.","journal-title":"Yonago Acta Med"},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbcan.2017.10.001","volume":"1868","author":"K Wu","year":"2017","unstructured":"Wu K, Xing F, Wu SY, Watabe K. Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside. Biochim Biophys Acta Rev Cancer. 2017;1868:538\u201363.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"793_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells8040307","volume":"8","author":"S Gurunathan","year":"2019","unstructured":"Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307.","journal-title":"Cells."},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.drudis.2017.03.004","volume":"22","author":"I Vanni","year":"2017","unstructured":"Vanni I, Alama A, Grossi F, Dal Bello MG, Coco S. Exosomes: a new horizon in lung cancer. Drug Discov Today. 2017;22:927\u201336.","journal-title":"Drug Discov Today"},{"issue":"11","key":"793_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/tra.12687","volume":"20","author":"M Vidal","year":"2019","unstructured":"Vidal M. Exosomes: revisiting their role as 'garbage bags'. Traffic (Copenhagen, Denmark). 2019;20(11):815-828.","journal-title":"Traffic (Copenhagen, Denmark)."},{"key":"793_CR18","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412\u201320.","journal-title":"J Biol Chem"},{"issue":"9","key":"793_CR19","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3390\/cells9091955","volume":"9","author":"F Royo","year":"2020","unstructured":"Royo F, Th\u00e9ry C, Falc\u00f3n-P\u00e9rez JM, Nieuwland R and Witwer KW. Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV Rigor and Standardization Subcommittee. Cells. 2020;9(9):1955.","journal-title":"Cells."},{"key":"793_CR20","doi-asserted-by":"publisher","first-page":"113594","DOI":"10.1016\/j.bios.2021.113594","volume":"194","author":"Z Yu","year":"2021","unstructured":"Yu Z, Lin S, Xia F, et al. ExoSD chips for high-purity immunomagnetic separation and high-sensitivity detection of gastric cancer cell-derived exosomes. Biosens Bioelectron. 2021;194:113594.","journal-title":"Biosens Bioelectron"},{"key":"793_CR21","doi-asserted-by":"publisher","first-page":"e1903916","DOI":"10.1002\/smll.201903916","volume":"16","author":"S Lin","year":"2020","unstructured":"Lin S, Yu Z, Chen D, et al. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications. Small. 2020;16:e1903916.","journal-title":"Small"},{"key":"793_CR22","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1039\/C5LC00240K","volume":"15","author":"A Liga","year":"2015","unstructured":"Liga A, Vliegenthart AD, Oosthuyzen W, Dear JW, Kersaudy-Kerhoas M. Exosome isolation: a microfluidic road-map. Lab Chip. 2015;15:2388\u201394.","journal-title":"Lab Chip"},{"key":"793_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4939-7231-9_22","volume":"1654","author":"M Pietrowska","year":"2017","unstructured":"Pietrowska M, Funk S, Gawin M, et al. Isolation of exosomes for the purpose of protein cargo analysis with the use of mass spectrometry. Methods Mol Biol (Clifton, NJ). 2017;1654:291\u2013307.","journal-title":"Methods Mol Biol (Clifton, N.J.)"},{"key":"793_CR24","doi-asserted-by":"publisher","unstructured":"Yang F, Liao X, Tian Y and Li G. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies. Biotechnol J. 2017;12(4). https:\/\/doi.org\/10.1002\/biot.201600699.","DOI":"10.1002\/biot.201600699"},{"key":"793_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.21037\/atm-21-2075","volume":"9","author":"H Wei","year":"2021","unstructured":"Wei H, Qian X, Xie F, Cui D. Isolation of exosomes from serum of patients with lung cancer: a comparison of the ultra-high speed centrifugation and precipitation methods. Ann Transl Med. 2021;9:882.","journal-title":"Ann Transl Med"},{"key":"793_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1538-7836.2009.03654.x","volume":"8","author":"Y Yuana","year":"2010","unstructured":"Yuana Y, Oosterkamp TH, Bahatyrova S, et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost JTH. 2010;8:315\u201323.","journal-title":"J Thromb Haemost JTH"},{"key":"793_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1039\/C6LC01302C","volume":"17","author":"R Friedrich","year":"2017","unstructured":"Friedrich R, Block S, Alizadehheidari M, et al. A nano flow cytometer for single lipid vesicle analysis. Lab Chip. 2017;17:830\u201341.","journal-title":"Lab Chip"},{"key":"793_CR28","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed. 2020;15:6917\u201334.","journal-title":"Int J Nanomed"},{"key":"793_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332\u201343.","journal-title":"Adv Drug Deliv Rev"},{"key":"793_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"EV Batrakova","year":"2015","unstructured":"Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Controll Release Off J Controll Release Soc. 2015;219:396\u2013405.","journal-title":"J Controll Release Off J Controll Release Soc"},{"key":"793_CR31","doi-asserted-by":"publisher","first-page":"119606","DOI":"10.1016\/j.biomaterials.2019.119606","volume":"230","author":"S Pan","year":"2020","unstructured":"Pan S, Pei L, Zhang A, et al. Passion fruit-like exosome-PMA\/Au-BSA@Ce6 nanovehicles for real-time fluorescence imaging and enhanced targeted photodynamic therapy with deep penetration and superior retention behavior in tumor. Biomaterials. 2020;230:119606.","journal-title":"Biomaterials"},{"key":"793_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Ali DJ, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol. 2020;18:10.","journal-title":"J Nanobiotechnol"},{"key":"793_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13046-016-0429-5","volume":"35","author":"W Xu","year":"2016","unstructured":"Xu W, Yang Z, Lu N. From pathogenesis to clinical application: insights into exosomes as transfer vectors in cancer. J Exp Clin Cancer Res CR. 2016;35:156.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"793_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/geno.2000.6452","volume":"71","author":"AE El-Husseini","year":"2001","unstructured":"El-Husseini AE, Fretier P, Vincent SR. Cloning and characterization of a gene (RNF22) encoding a novel brain expressed ring finger protein (BERP) that maps to human chromosome 11p15.5. Genomics. 2001;71:363\u20137.","journal-title":"Genomics"},{"key":"793_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.8469989","volume":"260","author":"M Koi","year":"1993","unstructured":"Koi M, Johnson LA, Kalikin LM, Little PF, Nakamura Y, Feinberg AP. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science (New York, NY). 1993;260:361\u20134.","journal-title":"Science (New York, N.Y.)"},{"key":"793_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/emmm.201100160","volume":"3","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol Med. 2011;3:513\u201327.","journal-title":"EMBO Mol Med"},{"key":"793_CR37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrmicro1248","volume":"3","author":"S Nisole","year":"2005","unstructured":"Nisole S, Stoye JP, Sa\u00efb A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005;3:799\u2013808.","journal-title":"Nat Rev Microbiol"},{"key":"793_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K Ozato","year":"2008","unstructured":"Ozato K, Shin DM, Chang TH, Morse HC 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849\u201360.","journal-title":"Nat Rev Immunol"},{"key":"793_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.bbrc.2018.03.046","volume":"498","author":"Y Song","year":"2018","unstructured":"Song Y, Guo Q, Gao S, Hua K. Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer. Biochem Biophys Res Commun. 2018;498:686\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"793_CR40","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3109\/00365521.2015.1124285","volume":"51","author":"MY Piao","year":"2016","unstructured":"Piao MY, Cao HL, He NN, et al. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development. Scand J Gastroenterol. 2016;51:572\u201382.","journal-title":"Scand J Gastroenterol"},{"key":"793_CR41","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3892\/mmr.2017.6164","volume":"15","author":"M Wang","year":"2017","unstructured":"Wang M, Wu J, Guo Y, Chang X, Cheng T. The tripartite motif-containing protein 3 on the proliferation and cytokine secretion of rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep. 2017;15:1607\u201312.","journal-title":"Mol Med Rep"},{"key":"793_CR42","first-page":"2431","volume":"11","author":"Y Li","year":"2019","unstructured":"Li Y, Zhu H, Wang J, Qian X, Li N. miR-4513 promotes breast cancer progression through targeting TRIM3. Am J Transl Res. 2019;11:2431\u20138.","journal-title":"Am J Transl Res"},{"key":"793_CR43","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.2147\/OTT.S219777","volume":"12","author":"Q Lu","year":"2019","unstructured":"Lu Q, Zhang Y, Ma L, et al. TRIM3 negatively regulates autophagy through promoting degradation of Beclin1 in ewing sarcoma cells. Onco Targets Ther. 2019;12:11587\u201395.","journal-title":"Onco Targets Ther"},{"key":"793_CR44","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2019.06.126","volume":"516","author":"Y Song","year":"2019","unstructured":"Song Y, Guo Q, Gao S, Hua K. miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3. Biochem Biophys Res Commun. 2019;516:872\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"793_CR45","doi-asserted-by":"publisher","first-page":"20139","DOI":"10.1002\/jcp.28615","volume":"234","author":"M Wang","year":"2019","unstructured":"Wang M, Wu J, Zhou E, Chang X, Gan J, Cheng T. Forkhead box o3a suppresses lipopolysaccharide-stimulated proliferation and inflammation in fibroblast-like synoviocytes through regulating tripartite motif-containing protein 3. J Cell Physiol. 2019;234:20139\u201348.","journal-title":"J Cell Physiol"},{"key":"793_CR46","first-page":"2833","volume":"18","author":"W Dong","year":"2019","unstructured":"Dong W, Qiu C, Gong D, et al. Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson\u2019s disease. Exp Ther Med. 2019;18:2833\u201342.","journal-title":"Exp Ther Med"},{"key":"793_CR47","first-page":"S140","volume":"11","author":"F Dokhaee","year":"2018","unstructured":"Dokhaee F, Mazhari S, Galehdari M, Bahadori Monfared A, Baghaei K. Evaluation of GKN1 and GKN2 gene expression as a biomarker of gastric cancer. Gastroenterol Hepatol Bed Bench. 2018;11:S140-s145.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"793_CR48","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/CMAR.S194949","volume":"11","author":"OM Koper-Lenkiewicz","year":"2019","unstructured":"Koper-Lenkiewicz OM, Kami\u0144ska J, Gawro\u0144ska B, Matowicka-Karna J. The role and diagnostic potential of gastrokine 1 in gastric cancer. Cancer Manag Res. 2019;11:1921\u201331.","journal-title":"Cancer Manag Res"},{"key":"793_CR49","doi-asserted-by":"publisher","first-page":"G332","DOI":"10.1152\/ajpgi.00453.2002","volume":"285","author":"TE Martin","year":"2003","unstructured":"Martin TE, Powell CT, Wang Z, et al. A novel mitogenic protein that is highly expressed in cells of the gastric antrum mucosa. American journal of physiology. Gastrointest Liver Physiol. 2003;285:G332-343.","journal-title":"Gastrointest Liver Physiol"},{"key":"793_CR50","first-page":"956","volume":"21","author":"JH Yoon","year":"2018","unstructured":"Yoon JH, Ham IH, Kim O, et al. Gastrokine 1 protein is a potential theragnostic target for gastric cancer. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2018;21:956\u201367.","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"793_CR51","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1349-7006.2000.tb00967.x","volume":"91","author":"Y Yoshikawa","year":"2000","unstructured":"Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res Gann. 2000;91:459\u201363.","journal-title":"Jpn J Cancer Res Gann"},{"key":"793_CR52","first-page":"555","volume":"55","author":"J Alarc\u00f3n-Mill\u00e1n","year":"2019","unstructured":"Alarc\u00f3n-Mill\u00e1n J, Mart\u00ednez-Carrillo DN, Peralta-Zaragoza O, Fern\u00e1ndez-Tilapa G. Regulation of GKN1 expression in gastric carcinogenesis: a problem to resolve (Review). Int J Oncol. 2019;55:555\u201369.","journal-title":"Int J Oncol"},{"key":"793_CR53","doi-asserted-by":"publisher","first-page":"G109","DOI":"10.1152\/ajpgi.00374.2012","volume":"304","author":"TR Menheniott","year":"2013","unstructured":"Menheniott TR, Kurklu B, Giraud AS. Gastrokines: stomach-specific proteins with putative homeostatic and tumor suppressor roles. American journal of physiology. Gastrointest Liver Physiol. 2013;304:G109-121.","journal-title":"Gastrointest Liver Physiol"},{"key":"793_CR54","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1158\/1078-0432.CCR-07-4381","volume":"14","author":"SF Moss","year":"2008","unstructured":"Moss SF, Lee JW, Sabo E, et al. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1\/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:4161\u20137.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"793_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0968-0004(02)02134-5","volume":"27","author":"L S\u00e1nchez-Pulido","year":"2002","unstructured":"S\u00e1nchez-Pulido L, Devos D, Valencia A. BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci. 2002;27:329\u201332.","journal-title":"Trends Biochem Sci"},{"key":"793_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1756-0500-2-180","volume":"2","author":"J Hedlund","year":"2009","unstructured":"Hedlund J, Johansson J, Persson B. BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Notes. 2009;2:180.","journal-title":"BMC Res Notes"},{"key":"793_CR57","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1039\/c2mb25308a","volume":"9","author":"LM Pavone","year":"2013","unstructured":"Pavone LM, Del Vecchio P, Mallardo P, et al. Structural characterization and biological properties of human gastrokine 1. Mol BioSyst. 2013;9:412\u201321.","journal-title":"Mol BioSyst"},{"key":"793_CR58","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bbrc.2013.09.123","volume":"440","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, Choi YJ, Choi WS, Nam SW, Lee JY, Park WS. Functional analysis of the NH2-terminal hydrophobic region and BRICHOS domain of GKN1. Biochem Biophys Res Commun. 2013;440:689\u201395.","journal-title":"Biochem Biophys Res Commun"},{"key":"793_CR59","doi-asserted-by":"publisher","first-page":"16702","DOI":"10.3748\/wjg.v20.i44.16702","volume":"20","author":"XY Guo","year":"2014","unstructured":"Guo XY, Dong L, Qin B, Jiang J, Shi AM. Decreased expression of gastrokine 1 in gastric mucosa of gastric cancer patients. World J Gastroenterol. 2014;20:16702\u20136.","journal-title":"World J Gastroenterol"},{"key":"793_CR60","first-page":"381","volume":"19","author":"O Kim","year":"2016","unstructured":"Kim O, Yoon JH, Choi WS, et al. Gastrokine 1 inhibits gastrin-induced cell proliferation. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2016;19:381\u201391.","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"793_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gut.2010.230623","volume":"61","author":"R Xing","year":"2012","unstructured":"Xing R, Li W, Cui J, et al. Gastrokine 1 induces senescence through p16\/Rb pathway activation in gastric cancer cells. Gut. 2012;61:43\u201352.","journal-title":"Gut"},{"key":"793_CR62","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcb.24524","volume":"114","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, Cho ML, Choi YJ, et al. Gastrokine 1 regulates NF-\u03baB signaling pathway and cytokine expression in gastric cancers. J Cell Biochem. 2013;114:1800\u20139.","journal-title":"J Cell Biochem"},{"key":"793_CR63","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1002\/cam4.2457","volume":"8","author":"JH Yoon","year":"2019","unstructured":"Yoon JH, Park YG, Nam SW, Park WS. The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer. Cancer Med. 2019;8:5507\u201314.","journal-title":"Cancer Med"},{"key":"793_CR64","doi-asserted-by":"crossref","unstructured":"Yoon JH, Ashktorab H, Smoot DT, Nam SW, Hur H, Park WS Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2020.","DOI":"10.1007\/s10120-020-01068-2"},{"key":"793_CR65","first-page":"2199","volume":"7","author":"EY Yen","year":"2017","unstructured":"Yen EY, Miaw SC, Yu JS, Lai IR. Exosomal TGF-\u03b21 is correlated with lymphatic metastasis of gastric cancers. Am J Cancer Res. 2017;7:2199\u2013208.","journal-title":"Am J Cancer Res"},{"key":"793_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fonc.2014.00094","volume":"4","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Yu N, Lee C. Mysteries of TGF-\u03b2 paradox in benign and malignant cells. Front Oncol. 2014;4:94.","journal-title":"Front Oncol"},{"key":"793_CR67","doi-asserted-by":"publisher","first-page":"111520","DOI":"10.1016\/j.ejmech.2019.07.023","volume":"181","author":"JW Zhao","year":"2019","unstructured":"Zhao JW, Wu ZH, Guo JW, et al. Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal\/coumarin\/quinoline moieties. Eur J Med Chem. 2019;181:111520.","journal-title":"Eur J Med Chem"},{"key":"793_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1359-6101(96)00042-1","volume":"7","author":"L Attisano","year":"1996","unstructured":"Attisano L, Wrana JL. Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev. 1996;7:327\u201339.","journal-title":"Cytokine Growth Factor Rev"},{"key":"793_CR69","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1083\/jcb.110.4.1361","volume":"110","author":"RM Lyons","year":"1990","unstructured":"Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol. 1990;110:1361\u20137.","journal-title":"J Cell Biol"},{"key":"793_CR70","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.106.5.1659","volume":"106","author":"RM Lyons","year":"1988","unstructured":"Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988;106:1659\u201365.","journal-title":"J Cell Biol"},{"issue":"Pt 3","key":"793_CR71","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/bj3520601","volume":"352","author":"R Okl\u00fc","year":"2000","unstructured":"Okl\u00fc R, Hesketh R. The latent transforming growth factor beta binding protein (LTBP) family. Biochem J. 2000;352(Pt 3):601\u201310.","journal-title":"Biochem J"},{"key":"793_CR72","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","volume":"103","author":"J Massagu\u00e9","year":"2000","unstructured":"Massagu\u00e9 J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295\u2013309.","journal-title":"Cell"},{"key":"793_CR73","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3389\/fimmu.2019.01741","volume":"10","author":"XS Liu","year":"2019","unstructured":"Liu XS, Lin XK, Mei Y, et al. Regulatory T cells promote overexpression of Lgr5 on gastric cancer cells via TGF-beta1 and confer poor prognosis in gastric cancer. Front Immunol. 2019;10:1741.","journal-title":"Front Immunol"},{"key":"793_CR74","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer. 2010;10:415\u201324.","journal-title":"Nat Rev Cancer"},{"key":"793_CR75","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1053\/j.gastro.2011.07.048","volume":"141","author":"BR Achyut","year":"2011","unstructured":"Achyut BR, Yang L. Transforming growth factor-\u03b2 in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141:1167\u201378.","journal-title":"Gastroenterology"},{"key":"793_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12885-016-2091-x","volume":"16","author":"KH Pak","year":"2016","unstructured":"Pak KH, Kim DH, Kim H, Lee DH, Cheong JH. Differences in TGF-\u03b21 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer. BMC Cancer. 2016;16:60.","journal-title":"BMC Cancer"},{"key":"793_CR77","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12885-019-5972-y","volume":"19","author":"KH Pak","year":"2019","unstructured":"Pak KH, Park KC, Cheong JH. VEGF-C induced by TGF- \u03b21 signaling in gastric cancer enhances tumor-induced lymphangiogenesis. BMC Cancer. 2019;19:799.","journal-title":"BMC Cancer"},{"key":"793_CR78","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1111\/jcmm.13847","volume":"22","author":"Y Che","year":"2018","unstructured":"Che Y, Geng B, Xu Y, et al. Helicobacter pylori-induced exosomal MET educates tumour-associated macrophages to promote gastric cancer progression. J Cell Mol Med. 2018;22:5708\u201319.","journal-title":"J Cell Mol Med"},{"key":"793_CR79","doi-asserted-by":"publisher","first-page":"e0413","DOI":"10.1097\/MD.0000000000010413","volume":"97","author":"Z Zou","year":"2018","unstructured":"Zou Z, Zhao L, Su S, et al. The plasma levels of 12 cytokines and growth factors in patients with gastric cancer. Medicine. 2018;97:e0413.","journal-title":"Medicine"},{"key":"793_CR80","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1158\/2326-6066.CIR-16-0152","volume":"5","author":"LS Peng","year":"2017","unstructured":"Peng LS, Zhang JY, Teng YS, et al. Tumor-associated monocytes\/macrophages impair NK-cell function via TGF\u03b21 in human gastric cancer. Cancer Immunol Res. 2017;5:248\u201356.","journal-title":"Cancer Immunol Res"},{"key":"793_CR81","doi-asserted-by":"publisher","first-page":"6248590","DOI":"10.1155\/2018\/6248590","volume":"2018","author":"B Han","year":"2018","unstructured":"Han B, Mao FY, Zhao YL, et al. Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associated with tumor progression in human gastric cancer. J Immunol Res. 2018;2018:6248590.","journal-title":"J Immunol Res"},{"key":"793_CR82","first-page":"1472","volume":"54","author":"S Coban","year":"2007","unstructured":"Coban S, Y\u00fcksel O, Ko\u00e7kar MC, et al. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers. Hepatogastroenterology. 2007;54:1472\u20136.","journal-title":"Hepatogastroenterology"},{"key":"793_CR83","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1002\/jcb.27618","volume":"120","author":"H Wang","year":"2019","unstructured":"Wang H, Zhao Y, Cao L, Zhang J, Wang Y, Xu M. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K\/AKT signaling. J Cell Biochem. 2019;120:3447\u201354.","journal-title":"J Cell Biochem"},{"key":"793_CR84","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/ptr.6057","volume":"32","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wen K. Astragaloside IV inhibits TGF-\u03b21-induced epithelial-mesenchymal transition through inhibition of the PI3K\/Akt\/NF-\u03baB pathway in gastric cancer cells. Phytother Res PTR. 2018;32:1289\u201396.","journal-title":"Phytother Res PTR"},{"key":"793_CR85","doi-asserted-by":"publisher","unstructured":"Wang B, Chen H and Zhang Y. Involvement of GASL1 in postoperative distant recurrence of gastric adenocarcinoma after gastrectomy distal resection and the possible mechanism. J Cell Biochem. 2019. https:\/\/doi.org\/10.1002\/jcb.28423.","DOI":"10.1002\/jcb.28423"},{"key":"793_CR86","doi-asserted-by":"publisher","first-page":"e54249","DOI":"10.1371\/journal.pone.0054249","volume":"8","author":"GF Ma","year":"2013","unstructured":"Ma GF, Miao Q, Zeng XQ, et al. Transforming growth factor-\u03b21 and -\u03b22 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro. PLoS ONE. 2013;8:e54249.","journal-title":"PLoS ONE"},{"key":"793_CR87","first-page":"182","volume":"94","author":"A Suda","year":"2009","unstructured":"Suda A, Saito N, Seshimo A, Kameoka S, Kobayashi M. Examination of transforming growth factor beta1 expression in the serum and tumor tissue of gastric cancer. Int Surg. 2009;94:182\u20138.","journal-title":"Int Surg"},{"key":"793_CR88","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/jcla.20236","volume":"22","author":"X Li","year":"2008","unstructured":"Li X, Yue ZC, Zhang YY, et al. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J Clin Lab Anal. 2008;22:164\u201371.","journal-title":"J Clin Lab Anal"},{"key":"793_CR89","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cas.13158","volume":"108","author":"I Hoshino","year":"2017","unstructured":"Hoshino I, Nagata M, Takiguchi N, et al. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Cancer Sci. 2017;108:308\u201315.","journal-title":"Cancer Sci"},{"key":"793_CR90","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3109\/02656736.2011.564598","volume":"27","author":"H Zhong","year":"2011","unstructured":"Zhong H, Yang Y, Ma S, et al. Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients. Int J Hyperth Off J Eur Soc Hyperth Oncol North Am Hyperth Group. 2011;27:604\u201311.","journal-title":"Int J Hyperth Off J Eur Soc Hyperth Oncol North Am Hyperth Group"},{"key":"793_CR91","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.3748\/wjg.v21.i20.6215","volume":"21","author":"C Li","year":"2015","unstructured":"Li C, Liu DR, Li GG, et al. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. World J Gastroenterol. 2015;21:6215\u201328.","journal-title":"World J Gastroenterol"},{"key":"793_CR92","first-page":"754","volume":"19","author":"D Liu","year":"2016","unstructured":"Liu D, Li C, Trojanowicz B, et al. CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2016;19:754\u201366.","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"793_CR93","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3892\/ol.2020.11849","volume":"20","author":"F Liu","year":"2020","unstructured":"Liu F, Wang H, Zhang M. Distinct prognostic values and antitumor effects of tumor growth factor \u03b21 and its receptors in gastric cancer. Oncol Lett. 2020;20:2621\u201332.","journal-title":"Oncol Lett"},{"key":"793_CR94","doi-asserted-by":"publisher","first-page":"e1705054","DOI":"10.1002\/adma.201705054","volume":"30","author":"C Qiao","year":"2018","unstructured":"Qiao C, Yang J, Shen Q, et al. Traceable nanoparticles with dual targeting and ROS response for RNAi-based immunochemotherapy of intracranial glioblastoma treatment. Adv Mater (Deerfield Beach, Fla). 2018;30:e1705054.","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"key":"793_CR95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","volume":"109","author":"QL Li","year":"2002","unstructured":"Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002;109:113\u201324.","journal-title":"Cell"},{"key":"793_CR96","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mce.2008.08.017","volume":"294","author":"MA Memon","year":"2008","unstructured":"Memon MA, Anway MD, Covert TR, Uzumcu M, Skinner MK. Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development. Mol Cell Endocrinol. 2008;294:70\u201380.","journal-title":"Mol Cell Endocrinol"},{"key":"793_CR97","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.18632\/aging.102329","volume":"11","author":"T Yang","year":"2019","unstructured":"Yang T, Huang T, Zhang D, et al. TGF-\u03b2 receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-\u03b2\/SMAD4 signaling pathway. Aging. 2019;11:8892\u2013910.","journal-title":"Aging"},{"key":"793_CR98","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/bs.vh.2015.06.002","volume":"99","author":"AC Carreira","year":"2015","unstructured":"Carreira AC, Zambuzzi WF, Rossi MC, Astorino Filho R, Sogayar MC, Granjeiro JM. bone morphogenetic proteins: promising molecules for bone healing, bioengineering, and regenerative medicine. Vitam Horm. 2015;99:293\u2013322.","journal-title":"Vitam Horm"},{"key":"793_CR99","first-page":"2331","volume":"9","author":"Y Cui","year":"2019","unstructured":"Cui Y, Zhang F, Jia Y, et al. The BMP antagonist, SOSTDC1, restrains gastric cancer progression via inactivation of c-Jun signaling. Am J Cancer Res. 2019;9:2331\u201348.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"793_CR100","doi-asserted-by":"publisher","first-page":"jcs237222","DOI":"10.1242\/jcs.237222","volume":"133","author":"G Deng","year":"2020","unstructured":"Deng G, Chen Y, Guo C, et al. BMP4 promotes the metastasis of gastric cancer by inducing epithelial-mesenchymal transition via ID1. J Cell Sci. 2020;133(11):jcs237222.","journal-title":"J Cell Sci."},{"key":"793_CR101","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s13277-015-4116-5","volume":"37","author":"H Lei","year":"2016","unstructured":"Lei H, Wang J, Lu P, et al. BMP10 inhibited the growth and migration of gastric cancer cells. Tumour Biol J Int Soc Oncodev Biol Med. 2016;37:3025\u201331.","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med"},{"key":"793_CR102","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12885-018-4383-9","volume":"18","author":"YY Hsieh","year":"2018","unstructured":"Hsieh YY, Tung SY, Pan HY, et al. Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients. BMC Cancer. 2018;18:508.","journal-title":"BMC Cancer"},{"key":"793_CR103","doi-asserted-by":"publisher","first-page":"e52465","DOI":"10.1371\/journal.pone.0052465","volume":"7","author":"J Gu","year":"2012","unstructured":"Gu J, Qian H, Shen L, et al. Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-\u03b2\/Smad pathway. PLoS ONE. 2012;7:e52465.","journal-title":"PLoS ONE"},{"key":"793_CR104","first-page":"2350","volume":"24","author":"X Ning","year":"2018","unstructured":"Ning X, Zhang H, Wang C, Song X. Exosomes released by gastric cancer cells induce transition of pericytes into cancer-associated fibroblasts. Med Sci Monit Int Med J Exp Clin Res. 2018;24:2350\u20139.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"793_CR105","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"793_CR106","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3389\/fonc.2019.01308","volume":"9","author":"C Arienti","year":"2019","unstructured":"Arienti C, Pignatta S, Tesei A. Epidermal growth factor receptor family and its role in gastric cancer. Front Oncol. 2019;9:1308.","journal-title":"Front Oncol"},{"key":"793_CR107","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0021-9258(19)68224-4","volume":"257","author":"S Cohen","year":"1982","unstructured":"Cohen S, Ushiro H, Stoscheck C, Chinkers M. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem. 1982;257:1523\u201331.","journal-title":"J Biol Chem"},{"key":"793_CR108","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1158\/1078-0432.CCR-12-1318","volume":"18","author":"M Terashima","year":"2012","unstructured":"Terashima M, Kitada K, Ochiai A, et al. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II\/III gastric cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2012;18:5992\u20136000.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"793_CR109","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1158\/1078-0432.CCR-07-1898","volume":"14","author":"J Matsubara","year":"2008","unstructured":"Matsubara J, Yamada Y, Hirashima Y, et al. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:3022\u20139.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"793_CR110","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1053\/j.gastro.2014.02.005","volume":"146","author":"R Chaturvedi","year":"2014","unstructured":"Chaturvedi R, Asim M, Piazuelo MB, et al. Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Gastroenterology. 2014;146:1739-1751.e1714.","journal-title":"Gastroenterology"},{"key":"793_CR111","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-11-3893","volume":"72","author":"AM Dulak","year":"2012","unstructured":"Dulak AM, Schumacher SE, van Lieshout J, et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Can Res. 2012;72:4383\u201393.","journal-title":"Can Res"},{"key":"793_CR112","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2559.2008.03021.x","volume":"52","author":"MA Kim","year":"2008","unstructured":"Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology. 2008;52:738\u201346.","journal-title":"Histopathology"},{"key":"793_CR113","doi-asserted-by":"publisher","first-page":"17202","DOI":"10.18632\/oncotarget.15231","volume":"8","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Tang H, Lin J, et al. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: an updated meta-analysis. Oncotarget. 2017;8:17202\u201315.","journal-title":"Oncotarget"},{"key":"793_CR114","doi-asserted-by":"publisher","first-page":"e85388","DOI":"10.1371\/journal.pone.0085388","volume":"9","author":"R Terragni","year":"2014","unstructured":"Terragni R, Casadei Gardini A, Sabattini S, et al. EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? PLoS ONE. 2014;9:e85388.","journal-title":"PLoS ONE"},{"key":"793_CR115","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/ncomms15016","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, Deng T, Liu R, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2017;8:15016.","journal-title":"Nat Commun"},{"key":"793_CR116","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1073\/pnas.90.12.5791","volume":"90","author":"A Covacci","year":"1993","unstructured":"Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993;90:5791\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"793_CR117","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.chom.2012.05.010","volume":"12","author":"T Hayashi","year":"2012","unstructured":"Hayashi T, Senda M, Morohashi H, et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe. 2012;12:20\u201333.","journal-title":"Cell Host Microbe"},{"key":"793_CR118","doi-asserted-by":"publisher","first-page":"14640","DOI":"10.1073\/pnas.1206098109","volume":"109","author":"B Kaplan-T\u00fcrk\u00f6z","year":"2012","unstructured":"Kaplan-T\u00fcrk\u00f6z B, Jim\u00e9nez-Soto LF, Dian C, et al. Structural insights into Helicobacter pylori oncoprotein CagA interaction with \u03b21 integrin. Proc Natl Acad Sci USA. 2012;109:14640\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"793_CR119","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/apm.13034","volume":"128","author":"A Sukri","year":"2020","unstructured":"Sukri A, Hanafiah A, Mohamad Zin N, Kosai NR. Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis. APMIS Acta Pathol Microbiol Immunol Scand. 2020;128:150\u201361.","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"793_CR120","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1073\/pnas.0711183105","volume":"105","author":"N Ohnishi","year":"2008","unstructured":"Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105:1003\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"793_CR121","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/toxins10040163","volume":"10","author":"JY Park","year":"2018","unstructured":"Park JY, Forman D, Waskito LA, Yamaoka Y and Crabtree JE. Epidemiology of helicobacter pylori and CagA-positive infections and global variations in gastric cancer. Toxins. 2018;10(4):163.","journal-title":"Toxins."},{"key":"793_CR122","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4166\/kjg.2015.66.2.75","volume":"66","author":"YJ Na","year":"2015","unstructured":"Na YJ, Shim KN, Joo YH, et al. RUNX3 methylation, loss of RUNX3 expression and clinicopathologic findings according to helicobacter pylori CagA in gastric carcinoma. Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi. 2015;66:75\u201384.","journal-title":"Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi"},{"key":"793_CR123","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/00365520601173863","volume":"42","author":"JH Sim\u00e1n","year":"2007","unstructured":"Sim\u00e1n JH, Engstrand L, Berglund G, Forsgren A, Flor\u00e9n CH. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol. 2007;42:933\u201340.","journal-title":"Scand J Gastroenterol"},{"key":"793_CR124","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41423-019-0339-5","volume":"17","author":"A Takahashi-Kanemitsu","year":"2020","unstructured":"Takahashi-Kanemitsu A, Knight CT, Hatakeyama M. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol. 2020;17:50\u201363.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"793_CR125","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/ijms21010224","volume":"21","author":"B Liu","year":"2019","unstructured":"Liu B, Li X, Sun F, et al. HP-CagA+ regulates the expression of CDK4\/CyclinD1 via reg3 to change cell cycle and promote cell proliferation. Int J Mol Sci. 2019;21(1):224.","journal-title":"Int J Mol Sci."},{"key":"793_CR126","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1172\/JCI130015","volume":"130","author":"M Palrasu","year":"2020","unstructured":"Palrasu M, Zaika E, El-Rifai W, et al. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Investig. 2020;130:2422\u201334.","journal-title":"J Clin Investig"},{"key":"793_CR127","doi-asserted-by":"publisher","first-page":"18346","DOI":"10.1038\/srep18346","volume":"6","author":"A Shimoda","year":"2016","unstructured":"Shimoda A, Ueda K, Nishiumi S, et al. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep. 2016;6:18346.","journal-title":"Sci Rep"},{"key":"793_CR128","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1749-6632.1996.tb34412.x","volume":"777","author":"RW Mahley","year":"1996","unstructured":"Mahley RW, Nathan BP, Pitas RE. Apolipoprotein E Structure, function, and possible roles in Alzheimer\u2019s disease. Ann N Y Acad Sci. 1996;777:139\u201345.","journal-title":"Ann N Y Acad Sci"},{"key":"793_CR129","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1158\/0008-5472.CAN-09-1734","volume":"69","author":"LE Moore","year":"2009","unstructured":"Moore LE, Brennan P, Karami S, et al. Apolipoprotein E\/C1 locus variants modify renal cell carcinoma risk. Can Res. 2009;69:8001\u20138.","journal-title":"Can Res"},{"key":"793_CR130","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1385\/MN:23:1:53","volume":"23","author":"Y Li","year":"2001","unstructured":"Li Y, Cam J, Bu G. Low-density lipoprotein receptor family: endocytosis and signal transduction. Mol Neurobiol. 2001;23:53\u201367.","journal-title":"Mol Neurobiol"},{"key":"793_CR131","doi-asserted-by":"publisher","first-page":"43455","DOI":"10.1074\/jbc.M105325200","volume":"276","author":"YY Ho","year":"2001","unstructured":"Ho YY, Deckelbaum RJ, Chen Y, Vogel T, Talmage DA. Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem. 2001;276:43455\u201362.","journal-title":"J Biol Chem"},{"key":"793_CR132","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genom Hum Genet. 2000;1:507\u201337.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"793_CR133","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3892\/ol.2015.3447","volume":"10","author":"X Shi","year":"2015","unstructured":"Shi X, Xu J, Wang J, et al. Expression analysis of apolipoprotein E and its associated genes in gastric cancer. Oncol Lett. 2015;10:1309\u201314.","journal-title":"Oncol Lett"},{"key":"793_CR134","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jcb.240540306","volume":"54","author":"T Vogel","year":"1994","unstructured":"Vogel T, Guo NH, Guy R, et al. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem. 1994;54:299\u2013308.","journal-title":"J Cell Biochem"},{"key":"793_CR135","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1006\/mcpr.1994.1073","volume":"8","author":"DC Rubinsztein","year":"1994","unstructured":"Rubinsztein DC, Hanlon CS, Irving RM, et al. Apo E genotypes in multiple sclerosis, Parkinson\u2019s disease, schwannomas and late-onset Alzheimer\u2019s disease. Mol Cell Probes. 1994;8:519\u201325.","journal-title":"Mol Cell Probes"},{"key":"793_CR136","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/01.ATV.20.4.1020","volume":"20","author":"M Ishigami","year":"2000","unstructured":"Ishigami M, Swertfeger DK, Hui MS, Granholm NA, Hui DY. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2000;20:1020\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"793_CR137","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/01.ATV.0000014587.66321.B4","volume":"22","author":"H Williams","year":"2002","unstructured":"Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22:788\u201392.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"793_CR138","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","volume":"256","author":"KH Weisgraber","year":"1981","unstructured":"Weisgraber KH, Rall SC Jr, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256:9077\u201383.","journal-title":"J Biol Chem"},{"key":"793_CR139","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1073\/pnas.79.15.4696","volume":"79","author":"SC Rall Jr","year":"1982","unstructured":"Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA. 1982;79:4696\u2013700.","journal-title":"Proc Natl Acad Sci USA"},{"key":"793_CR140","first-page":"1313","volume":"20","author":"K Sakashita","year":"2008","unstructured":"Sakashita K, Tanaka F, Zhang X, et al. Clinical significance of ApoE expression in human gastric cancer. Oncol Rep. 2008;20:1313\u20139.","journal-title":"Oncol Rep"},{"key":"793_CR141","doi-asserted-by":"publisher","first-page":"19930","DOI":"10.1038\/srep19930","volume":"6","author":"R Kang","year":"2016","unstructured":"Kang R, Li P, Wang T, et al. Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population. Sci Rep. 2016;6:19930.","journal-title":"Sci Rep"},{"key":"793_CR142","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41419-018-0465-5","volume":"9","author":"P Zheng","year":"2018","unstructured":"Zheng P, Luo Q, Wang W, et al. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E. Cell Death Dis. 2018;9:434.","journal-title":"Cell Death Dis"},{"key":"793_CR143","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/and.12569","volume":"48","author":"TJ Ma","year":"2016","unstructured":"Ma TJ, Zhang XJ, Ding XP, Chen HH, Zhang YW, Ding M. Association of single nucleotide polymorphisms in UBR2 gene with idiopathic aspermia or oligospermia in Sichuan, China. Andrologia. 2016;48:1253\u201360.","journal-title":"Andrologia"},{"key":"793_CR144","doi-asserted-by":"publisher","first-page":"e14017","DOI":"10.1371\/journal.pone.0014017","volume":"5","author":"F Yang","year":"2010","unstructured":"Yang F, Cheng Y, An JY, et al. The ubiquitin ligase Ubr2, a recognition E3 component of the N-end rule pathway, stabilizes Tex19.1 during spermatogenesis. PLoS ONE. 2010;5:e14017.","journal-title":"PLoS ONE"},{"key":"793_CR145","doi-asserted-by":"publisher","first-page":"e37414","DOI":"10.1371\/journal.pone.0037414","volume":"7","author":"JY An","year":"2012","unstructured":"An JY, Kim E, Zakrzewska A, et al. UBR2 of the N-end rule pathway is required for chromosome stability via histone ubiquitylation in spermatocytes and somatic cells. PLoS ONE. 2012;7:e37414.","journal-title":"PLoS ONE"},{"key":"793_CR146","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.1128\/MCB.23.22.8255-8271.2003","volume":"23","author":"YT Kwon","year":"2003","unstructured":"Kwon YT, Xia Z, An JY, et al. Female lethality and apoptosis of spermatocytes in mice lacking the UBR2 ubiquitin ligase of the N-end rule pathway. Mol Cell Biol. 2003;23:8255\u201371.","journal-title":"Mol Cell Biol"},{"key":"793_CR147","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.1158\/0008-5472.CAN-04-2102","volume":"64","author":"KS Kwak","year":"2004","unstructured":"Kwak KS, Zhou X, Solomon V, et al. Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia. Can Res. 2004;64:8193\u20138.","journal-title":"Can Res"},{"key":"793_CR148","doi-asserted-by":"publisher","first-page":"e101996","DOI":"10.15252\/embj.2019101996","volume":"38","author":"H Xu","year":"2019","unstructured":"Xu H, Shi J, Gao H, et al. The N-end rule ubiquitin ligase UBR2 mediates NLRP1B inflammasome activation by anthrax lethal toxin. EMBO J. 2019;38:e101996.","journal-title":"EMBO J"},{"key":"793_CR149","first-page":"2893","volume":"27","author":"G Zhang","year":"2013","unstructured":"Zhang G, Lin RK, Kwon YT, Li YP. Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2. FASEB J Off Publ Fed Am Soc Exp Biol. 2013;27:2893\u2013901.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"793_CR150","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/stem.2702","volume":"35","author":"J Mao","year":"2017","unstructured":"Mao J, Liang Z, Zhang B, et al. UBR2 enriched in p53 deficient mouse bone marrow mesenchymal stem cell-exosome promoted gastric cancer progression via Wnt\/\u03b2-catenin pathway. Stem Cells (Dayton, Ohio). 2017;35:2267\u201379.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"793_CR151","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1002\/jcp.29233","volume":"235","author":"J Fang","year":"2020","unstructured":"Fang J, Ge X, Xu W, et al. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer. J Cell Physiol. 2020;235:3438\u201346.","journal-title":"J Cell Physiol"},{"key":"793_CR152","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.sla.0000149300.28588.23","volume":"241","author":"BJ Dicken","year":"2005","unstructured":"Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27\u201339.","journal-title":"Ann Surg"},{"key":"793_CR153","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0959-437X(03)00023-6","volume":"13","author":"A Agresti","year":"2003","unstructured":"Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Opin Genet Dev. 2003;13:170\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"793_CR154","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11010-009-0305-0","volume":"337","author":"N Kostova","year":"2010","unstructured":"Kostova N, Zlateva S, Ugrinova I, Pasheva E. The expression of HMGB1 protein and its receptor RAGE in human malignant tumors. Mol Cell Biochem. 2010;337:251\u20138.","journal-title":"Mol Cell Biochem"},{"key":"793_CR155","first-page":"101","volume":"1799","author":"M Stros","year":"2010","unstructured":"Stros M. HMGB proteins: interactions with DNA and chromatin. Biochem Biophys Acta. 2010;1799:101\u201313.","journal-title":"Biochem Biophys Acta"},{"issue":"31","key":"793_CR156","doi-asserted-by":"publisher","first-page":"50417","DOI":"10.18632\/oncotarget.10413","volume":"7","author":"T Wu","year":"2016","unstructured":"Wu T, Zhang W, Yang G, et al. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review. Oncotarget. 2016;7(31):50417\u201327.","journal-title":"Oncotarget"},{"key":"793_CR157","first-page":"1","volume":"3","author":"ZS Guo","year":"2013","unstructured":"Guo ZS, Liu Z, Bartlett DL, Tang D, Lotze MT. Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res. 2013;3:1\u201320.","journal-title":"Am J Cancer Res"},{"key":"793_CR158","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1432-1033.1973.tb03026.x","volume":"38","author":"GH Goodwin","year":"1973","unstructured":"Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem. 1973;38:14\u20139.","journal-title":"Eur J Biochem"},{"key":"793_CR159","doi-asserted-by":"publisher","unstructured":"Tian L, Wang ZY, Hao J and Zhang XY. miR-505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1. J Cell Biochem. 2018. https:\/\/doi.org\/10.1002\/jcb.28082.","DOI":"10.1002\/jcb.28082"},{"key":"793_CR160","first-page":"3453706","volume":"2018","author":"X Wu","year":"2018","unstructured":"Wu X, Wang W, Chen Y, et al. High mobility group box protein 1 serves as a potential prognostic marker of lung cancer and promotes its invasion and metastasis by matrix metalloproteinase-2 in a nuclear factor-\u03baB-dependent manner. Biomed Res Int. 2018;2018:3453706.","journal-title":"Biomed Res Int"},{"key":"793_CR161","doi-asserted-by":"publisher","first-page":"39888","DOI":"10.1074\/jbc.M110.128348","volume":"285","author":"J Evankovich","year":"2010","unstructured":"Evankovich J, Cho SW, Zhang R, et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem. 2010;285:39888\u201397.","journal-title":"J Biol Chem"},{"key":"793_CR162","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/srep16013","volume":"5","author":"W Zeng","year":"2015","unstructured":"Zeng W, Shan W, Gao L, et al. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep. 2015;5:16013.","journal-title":"Sci Rep"},{"key":"793_CR163","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cbf.1811","volume":"30","author":"B Song","year":"2012","unstructured":"Song B, Song WG, Li ZJ, et al. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem Funct. 2012;30:11\u20137.","journal-title":"Cell Biochem Funct"},{"key":"793_CR164","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3892\/ijo.2014.2285","volume":"44","author":"J Zhang","year":"2014","unstructured":"Zhang J, Kou YB, Zhu JS, Chen WX, Li S. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-\u03baB pathway in vitro and in vivo. Int J Oncol. 2014;44:1268\u201376.","journal-title":"Int J Oncol"},{"key":"793_CR165","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1038\/s41598-018-25443-3","volume":"8","author":"H Wang","year":"2018","unstructured":"Wang H, Chen Y, Guo J, et al. Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1. Sci Rep. 2018;8:7080.","journal-title":"Sci Rep"},{"key":"793_CR166","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/cas.13288","volume":"108","author":"HW Chung","year":"2017","unstructured":"Chung HW, Lim JB. High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression. Cancer Sci. 2017;108:1594\u2013601.","journal-title":"Cancer Sci"},{"key":"793_CR167","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/DDDT.S201818","volume":"13","author":"H Tao","year":"2019","unstructured":"Tao H, Tang T, Wang S, et al. The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1. Drug Des Dev Ther. 2019;13:1221\u201331.","journal-title":"Drug Des Dev Ther"},{"key":"793_CR168","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/CMAR.S207934","volume":"12","author":"AA Ghweil","year":"2020","unstructured":"Ghweil AA, Osman HA, Hassan MH, et al. Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer. Cancer Manag Res. 2020;12:117\u201326.","journal-title":"Cancer Manag Res"},{"key":"793_CR169","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-018-0898-6","volume":"17","author":"X Zhang","year":"2018","unstructured":"Zhang X, Shi H, Yuan X, Jiang P, Qian H, Xu W. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration. Mol Cancer. 2018;17:146.","journal-title":"Mol Cancer"},{"key":"793_CR170","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1038\/cddis.2014.263","volume":"5","author":"Q Zhu","year":"2014","unstructured":"Zhu Q, Zhang X, Zhang L, et al. The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression. Cell Death Disease. 2014;5:e1295.","journal-title":"Cell Death Disease"},{"key":"793_CR171","doi-asserted-by":"publisher","first-page":"458","DOI":"10.21037\/atm.2017.09.07","volume":"5","author":"JT J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen JT, Nielsen KB, Mollerup J, Jepsen A, Go N. Detection of MET amplification in gastroesophageal tumor specimens using IQFISH. Ann Transl Med. 2017;5:458.","journal-title":"Ann Transl Med"},{"key":"793_CR172","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1126\/science.1846706","volume":"251","author":"DP Bottaro","year":"1991","unstructured":"Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (New York, NY). 1991;251:802\u20134.","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"793_CR173","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/molecules25030451","volume":"25","author":"C Xia","year":"2020","unstructured":"Xia C, Wang Y, Liu C, et al. Novel Peptide CM 7 Targeted c-met with antitumor activity. Molecules (Basel, Switzerland). 2020;25(3):451.","journal-title":"Molecules (Basel, Switzerland)."},{"key":"793_CR174","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1517\/14728222.2012.680957","volume":"16","author":"F Cecchi","year":"2012","unstructured":"Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF\/Met signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:553\u201372.","journal-title":"Expert Opin Ther Targets"},{"key":"793_CR175","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1158\/1078-0432.CCR-14-1293","volume":"20","author":"DL Jardim","year":"2014","unstructured":"Jardim DL, Tang C, Gagliato Dde M, et al. Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson phase I CLINIC. Clin Cancer Res Off J Am Assoc Cancer Res. 2014;20:6336\u201345.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"793_CR176","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Xia M, Jin K, et al. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Mol Cancer. 2018;17:45.","journal-title":"Mol Cancer"},{"key":"793_CR177","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1177\/1758834011422556","volume":"3","author":"SL Organ","year":"2011","unstructured":"Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011;3:S7-s19.","journal-title":"Ther Adv Med Oncol"},{"key":"793_CR178","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41568-018-0002-y","volume":"18","author":"PM Comoglio","year":"2018","unstructured":"Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer. 2018;18:341\u201358.","journal-title":"Nat Rev Cancer"},{"key":"793_CR179","first-page":"1632","volume":"26","author":"SY Ha","year":"2013","unstructured":"Ha SY, Lee J, Kang SY, et al. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Jl Modern Pathol Off J US Can Acad Pathol lnc. 2013;26:1632\u201341.","journal-title":"Jl Modern Pathol Off J US Can Acad Pathol lnc"},{"key":"793_CR180","first-page":"1477","volume":"19","author":"U Drebber","year":"2008","unstructured":"Drebber U, Baldus SE, Nolden B, et al. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep. 2008;19:1477\u201383.","journal-title":"Oncol Rep"},{"key":"793_CR181","doi-asserted-by":"publisher","first-page":"10264","DOI":"10.18632\/oncotarget.14382","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Guo L, Liu X, Li W, Ying J. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma. Oncotarget. 2017;8:10264\u201373.","journal-title":"Oncotarget"},{"key":"793_CR182","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3389\/fonc.2020.01113","volume":"10","author":"XQ Ding","year":"2020","unstructured":"Ding XQ, Wang ZY, Xia D, Wang RX, Pan XR, Tong JH. Proteomic profiling of serum exosomes from patients with metastatic gastric cancer. Front Oncol. 2020;10:1113.","journal-title":"Front Oncol"},{"key":"793_CR183","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1586\/14737159.2015.1041378","volume":"15","author":"H Im","year":"2015","unstructured":"Im H, Shao H, Weissleder R, Castro CM, Lee H. Nano-plasmonic exosome diagnostics. Expert Rev Mol Diagn. 2015;15:725\u201333.","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00793-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00793-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00793-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T16:07:40Z","timestamp":1685203660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00793-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":183,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00793-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"11 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}